Postby boxhill » Wed Jun 06, 2018 8:13 am
My oncology practice states that any trials should include standard of care plus the thing being tried, no placebo-only situations. I'd ask yours.
According to what I've read, Stivarga is only approved for use AFTER treatment with other chemo regimens. You didn't have folfox or folfiri previously? I thought those were the standard first-line treatments. What did you have?
F, 64 at DX CRC Stage IV
3/17/18 blockage, r hemi
11 of 25 LN,5 mesentery nodes
5mm liver met
pT3 pN2b pM1
BRAF wild, KRAS G12D
dMMR, MSI-H
5/18 FOLFOX
7/18 and 11/18 CT NED
12/18 MRI 5mm liver mass, 2 LNs in porta hepatis
12/31/18 Keytruda
6/19 Multiphasic CT LNs normal, Liver stable
6/28/19 Pause Key, predisone for joint pain
7/31/19 Restart Key
9/19 CT stable
Pain: all fails but Celebrex
12/23/19 CT stable
5/20 MRI stable/NED
6/20 Stop Key
All MRIs NED